Compare SAIC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAIC | TMDX |
|---|---|---|
| Founded | 1969 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.2B |
| IPO Year | N/A | 2019 |
| Metric | SAIC | TMDX |
|---|---|---|
| Price | $114.73 | $135.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $119.44 | ★ $144.25 |
| AVG Volume (30 Days) | 555.9K | ★ 623.6K |
| Earning Date | 12-04-2025 | 02-26-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | 33.14 | ★ 170.70 |
| EPS | ★ 7.83 | 2.54 |
| Revenue | ★ $7,350,000,000.00 | $566,354,000.00 |
| Revenue This Year | N/A | $38.81 |
| Revenue Next Year | $1.75 | $20.49 |
| P/E Ratio | ★ $14.56 | $54.05 |
| Revenue Growth | N/A | ★ 41.20 |
| 52 Week Low | $84.16 | $55.00 |
| 52 Week High | $124.11 | $156.00 |
| Indicator | SAIC | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 75.22 | 58.51 |
| Support Level | $100.00 | $134.00 |
| Resistance Level | $103.58 | $133.29 |
| Average True Range (ATR) | 2.85 | 5.02 |
| MACD | 0.97 | 1.46 |
| Stochastic Oscillator | 95.03 | 69.70 |
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.